| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.032 | 0.8 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |